Aging brings changes we can see, like wrinkles and slower movement. It also brings quieter shifts — like lighter sleep or waking up more often at night. One issue many older adults experience — but ...
Alexion, AstraZeneca Rare Disease's Koselugo (selumetinib), an oral, selective MEK inhibitor, has been approved in Canada for the treatment of adult patients with neurofibromatosis type 1 (NF1) who ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果